Literature DB >> 17337460

A pooled analysis to study trends in exposure to antineoplastic drugs among nurses.

Wouter Fransman1, Susan Peelen, Simone Hilhorst, Nel Roeleveld, Dick Heederik, Hans Kromhout.   

Abstract

OBJECTIVES: Several studies have shown that exposure to antineoplastic drugs can cause toxic effects on reproductive health as well as carcinogenic effects. Numerous studies have corroborated that hospital workers are exposed to these drugs. This study focused on trends in exposure to antineoplastic drugs since the introduction of guidelines in The Netherlands.
METHODS: Data from three cross-sectional exposure surveys conducted in The Netherlands were pooled to examine trends in occupational exposure to cyclophosphamide. Nurses' 24 h urine samples were analyzed in separate fractions, surface contamination was determined and gloves used during preparation or while handling patient urine were collected. The difference in detectable urine samples between 1997 and 2000 was determined by a generalized estimating equations (GEE) binomial regression model. Mixed models were used to study the time trend in surface and glove contamination levels.
RESULTS: The percentage of nurses' urine samples with detectable cyclophosphamide had decreased 4-fold between 1997 and 2000. Median cyclophosphamide levels in the positive urine samples were 3-fold lower in 2000 than in 1997. Surface and glove contamination had statistically significantly decreased between 1997 and more recent years.
CONCLUSIONS: Nurses working at outpatient clinics or oncology wards are still being exposed to cyclophosphamide, but their exposure decreased considerably between 1997 and 2000, presumably due to the introduction of detailed guidelines and regulations in The Netherlands, the subsequent increased use of LuerLock connections and infusion systems prefilled with saline, and growing hazard awareness of nurses working with antineoplastic drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337460     DOI: 10.1093/annhyg/mel081

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  14 in total

1.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

Review 2.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

3.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

Review 4.  Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Authors:  Mohammad Javad Zare Sakhvidi; Mohammad Hajaghazadeh; Mehrdad Mostaghaci; Amir Houshang Mehrparvar; Fariba Zare Sakhvidi; Elham Naghshineh
Journal:  Int J Occup Environ Health       Date:  2016-04-25

5.  Occupational exposure to chemotherapy of pharmacy personnel at a single centre.

Authors:  Raveena Ramphal; Tejinder Bains; Geneviève Goulet; Régis Vaillancourt
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

Review 6.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

7.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

8.  Antineoplastic drug exposure in an ambulatory setting: a pilot study.

Authors:  Christopher R Friese; Cristin McArdle; Ting Zhao; Duxin Sun; Ivan Spasojevic; Martha Polovich; Marjorie C McCullagh
Journal:  Cancer Nurs       Date:  2015 Mar-Apr       Impact factor: 2.592

9.  Infantile neuroblastoma and maternal occupational exposure to medical agents.

Authors:  Yuhki Koga; Masafumi Sanefuji; Syunichiro Toya; Utako Oba; Kentaro Nakashima; Hiroaki Ono; Shunsuke Yamamoto; Maya Suzuki; Yuri Sonoda; Masanobu Ogawa; Hiroyuki Yamamoto; Koichi Kusuhara; Shouichi Ohga
Journal:  Pediatr Res       Date:  2021-07-09       Impact factor: 3.756

10.  Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs.

Authors:  Pamela A Ratner; John J Spinelli; Kris Beking; Maria Lorenzi; Yat Chow; Kay Teschke; Nhu D Le; Richard P Gallagher; Helen Dimich-Ward
Journal:  BMC Nurs       Date:  2010-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.